Investor Presentation • Aug 25, 2021
Investor Presentation
Open in ViewerOpens in native device viewer


This presentation does not constitute an offer to purchase the Company's securities or solicitation to receive such offers, and is designed solely to offer information as part of the Company's explanations on its 2021 H1 financial reports.
This presentation includes information regarding the Company's strategic plan for the years 2020-24. Accordingly, the presentation includes forward-looking information as defined in section 32A of the Securities Law 5728-1968.
The realization and/or non-realization of forward-looking information which is stated in the financial reports will be affected by risk factors that characterize the activities of the Company and group companies, as detailed in the Company's periodic reports, including changes in economic conditions, capital market in Israel and globally, the development of competition in the segments relevant to the group's activities, regulatory changes, changes in consumer preferences and consumption habits, a change in working assumptions or in the economic models and assumptions used by the consulting firm – that can not be estimated in advance and are not controlled by the Company. Hence, there is no certainty that the actual results and achievements of the Company in the future will be in accordance with these views and may differ, also substantially, from those presented in this presentation.
Furthermore, the presentation includes data and assessments based on external sources, the contents of which were not independently tested by the Company and therefore the Company is not responsible for their accuracy.
This presentation was drafted for the sake of convenience and needs to be reviewed along side with the Company's public reports, including 2021 H1 Financial Statements, which contain the complete information about the Company, before making any decision to invest in the Company's securities.
This presentation may include information that is presented differently from the way it was presented in the company's official reports, some information may be presented and/or categorized and/or edited and/or segmented differently from the company's official past reports.
For the avoidance of doubt, the Company does not undertake to update or change the information contained in this presentation.



Financial Results
Segment Breakdown
Investments
Appendix
Glossary



Strong capital position 186%
High growth and compelling returns

2016H1-2021H1
(1) As of August 22, 2021
(2) Based on yields in the general plans: Policies (1991-2003), Pension, and 12 in Provident Funds
(3) As of December 31, 2020 with transitional measures (standard model), after dividend distribution and transfer of shares of Phoenix pension and provident as dividend in kind during 2021

2016H1-2021H1




Comprehensive Net Profit NIS millions

Notes: Core fee businesses include agencies, Excellence, and Gama. Investments include yields and variable management fees above 3% (previously reported within Insurance). See Appendix D for a detailed breakdown of 2019-20. See Glossary for definition of Special Items.



(1) Including LAT restatement for 2018-19; 2020 figure is before dividend distribution
(2) Including approximately 230 NISm of Mehadrin shares as a dividend in kind
(3) Mid-term Target based on 5-year plan and assuming 3% return on investments. ROE target range assumes 3% to 4.8% return on Nostro investments (4.8% based on average actual annual return during 1.10.15-30.9.20)
(4) Including 2020 share buy-back program 26 NISm plus cash dividend 380 NISm 2020 distributed during 2021 H1
(5) 67 NISm during the reporting period and 7 NISm subsequent to balance sheet date



Currently assessing targets in light of performance and business opportunities


1 AUMs include Halman-Aldubi's 43 NISb corporate fund
2 Before dividend distribution of 0.4 NISb in March for 2020
3 Includes approximately 230 NISm of Mehadrin shares as a dividend in kind
4 Post report date, the Company completed a share purchase of additional 7 NISm
Note: Mid-term Targets based on 5-year plan and assuming 3% return on investments. ROE target range assumes 3% to 4.8% return on Nostro investments (4.8% based on average actual annual return during 1.10.15-30.9.20). Actual performance will depend on financial markets, macroeconomic growth, industry trends, company performance and other variables
Comprehensive Profit ROE

• Asset management: Growth in AUMs to 329 NISb (including Halman corporate fund), customer acquisition in private
• P&C: Growth in premium rate - above industry trends; continuous growth in Phoenix SMART direct sales
• Agencies: growth in sales and profit contribution
• Gama: growth, reported as credit segment


brokerage accounts








IPO Description
Business Highlights
Priorities Going Forward

| Description | • As part of strategic plan implementation (capital management), Phoenix Insurance subsidiary issued Restricted Tier 1 (RT1) subordinated bonds |
|---|---|
| • First RT1 issuance by Israeli insurance company, rated A+ by S&P • 200 NISm of issued to institutional investors via the Tel Aviv Stock Exchange, plus |
|
| additional 1,026 NISm to replace subordinated bonds held by Phoenix Holdings | |
| • Junior subordinated debt securities that qualify as tier 1 capital under Solvency II regime |
|
| Key Terms | • CPI-linked bearing interest rate of 2.29% (3.2% spread over government bond yield), payable semi-annually |
| • Issued for 50 years, with an early redemption option for issuer after 10 years, and then every five years |
|
| • Principal temporary write-down mechanism, subject to reaching 100% or 75% SCR triggers; write-up following write-down subject to Company's discretion and its capital position |
|
| • Phoenix Insurance: Increase of Solvency II capital ratio without issuing ordinary shares |
|
| Benefits | by maximizing allowed AT1 bucket |
| • Phoenix Holdings: Improvement of ROE and liquidity; reduction of weighted financing costs for the group; facilitation of dividend distribution |



Priorities for next quarters



Segment Breakdown
Investments
Appendix
Glossary



Premiums, Benefit Contributions, & Investment Contracts NISb




Comprehensive Net Profit

| Q2/2020 | 290 | 176 | 196 | 40 | 44 | 5 | 379 | (374) | (8) | 748 |
|---|---|---|---|---|---|---|---|---|---|---|
| Difference | (58) | (180) | 205 | (9) | 15 | 229 | (228) | 79 | (4) | 49 |

Significant quarterly
• Investment income
• 261 NISm profit from
• Special items include 223 NISm profit from
PBT during H1
operations
Gama IPO
contributed 553 NISm
returns


(*) Investment income and variable management fees above 3% annual return and after offsetting the guaranteed yield to policyholders (123 NISm) and interest expenses (**) For full 2020 breakdown please see Appendix C.


Comprehensive Net Profit NISm

| 18


Comprehensive Income Before Tax NISm


(*) Investment income and variable management fees above 3% annual return (previously reported within insurance underwriting) and after offsetting the guaranteed yield to policyholders and interest expenses (**) For full breakdown please see Appendix B. See segment breakdowns for further details per segment.

| 2020 | 2020H1 | 2021H1 | ||
|---|---|---|---|---|
| P&C | Expenses / Gross Earned Premiums | 5.08% | 4.66% | 4.57% |
| Health | Expenses / Gross Earned Premiums | 5.82% | 5.80% | 5.51% |
| Life | Expenses / AUM | 0.49% | 0.53% | 0.49% |
| Pension & Provident | Expenses / AUM | 0.23% | 0.26% | 0.22% |

1


Financial Results
Investments
Appendix
Glossary





| 1-6/2021 | 180 | 230 | - | - | 410 |
|---|---|---|---|---|---|
| 1-6/2020 | 168 | (90) | (10) | (1) | 67 |
| Q2/2021 | 108 | 124 | - | - | 232 |
| Q2/2020 | 135 | 177 | (21) | (1) | 290 |




(*) The underwriting earnings assume a real rate of return of 3%, investment income includes income from own (Nostro) investments above or below a 3% real return

LTS Combined – Life & Long-Term Savings AM
Performance improvement driven by investments

Comprehensive Income Before Tax (NISm)



Comprehensive Income Before Tax (NISm)
Comprehensive Income Before Tax (NISm)

| 26


Operating Profit (NIS m)

| 1-6/2021 | 69 | (8) | 61 |
|---|---|---|---|
| 1-6/2020 | 95 | - | 95 |
| Q2/2021 | 38 | (7) | 31 |
| Q2/2020 | 40 | - | 40 |
| Difference | (2) | (7) | (9) |



| 1-6/2021 | 270 | 12 | (174) | 3 | 111 | |
|---|---|---|---|---|---|---|
| 1-6/2020 | 193 | (4) | (117) | 6 | 78 | |
| Q2/2021 | 140 | 8 | (90) | 1 | 59 | |
| Q2/2020 | 92 | 2 | (52) | 2 | 44 | |
| Difference | 48 | 6 | (38) | (1) | 15 |


236
Comprehensive Income Before Tax (NISm)

| 1-6/2021 | 16 | 220 | 236 |
|---|---|---|---|
| 1-6/2020 | 10 | - | 10 |
| Q2/2021 | 12 | 223 | 235 |
| Q2/2020 | 5 | - | 5 |
| Difference | 7 | 223 | 230 |



(**) Investment fees above 3%.


Financial Results
Segment Breakdown
Appendix
Glossary






| 33
H1/21 financial market recovery and low global interest rates generated improved returns
1 Refers to yields in the general plan
2 The Company reported in Halman-Aldubi a one-time profit of \$2.2 M, some of which was recognized during the reporting period as a result of Riskified company holding


Financial Results
Segment Breakdown
Investments
Appendix
Glossary





(*) The company classified in relation to previous periods its variable management fees under 3% annual return to operation profit, Investment income and variable Mang. fees above 3% annual return and after offsetting the guaranteed yield to policyholders and interest expenses to capital market investments and actuarial research to special items.
| 36

| 37
(*) The company classified in relation to previous periods its variable management fees under 3% annual return to operation profit, Investment income and variable Mang. fees above 3% annual return and after offsetting the guaranteed yield to policyholders and interest expenses to capital market investments and actuarial research to special items.

(*) The company classified in relation to previous periods its variable management fees under 3% annual return to operation profit, investment income and variable management fees above 3% annual return and after offsetting the guaranteed yield to policyholders and interest expenses to capital market investments and actuarial research to special items


Financial Results
Segment Breakdown
Investments
Appendix
Glossary



| AM | Asset Management; i.e. Excellence Nessuah |
|---|---|
| AUM | Assets Under Management; the total market value of all the investments that are managed by the Group |
| Bps | Basis Points; 1 basis points is .01% |
| CGU | Cost Generating Unit |
| CI | Comprehensive Income |
| CLR | Combined Loss Ratio |
| CO | Corporate, Other and Consolidation |
| CPI | Consumer Price Index; measures the average change of prices in an agreed upon basket of consumer goods and services over time |
| CSM | Contractual Service Margin |
| D&O | Directors and Officers Liability Insurance |
| DAC | Deferred Acquisition Cost |
| ESOP | Employee Stock Ownership Plan; workplace benefit program, that provides the employees with ownership interest in the company. |
| ETF | Exchange Traded Fund; an open end, tradable basket of securities that tracks an underling index, sector, or security type |
| Fixed-Rate Gov Bonds | A government issued bond for which the interest income payment is agreed upon and does not change |
| FX | Foreign Exchange Currency |
| Gama | Financial services and credit company owned by the Phoenix Group |
| Halman corporate funds | Israeli Electric Company (IEC) |
| Illiquidity Premium | Or Liquidity Premium; premium demanded by investors when any given security cannot be easily converted into cash for its fair market value. |
| IMF | International Monetary Fund |
| Index Linked Gov Bonds | A government issued bond for which the interest income payment is related (or linked) to the CPI |
| LAT | Liability Adequacy Test |
| Liquidity Premium | See Illiquidity Premium |
| LOB | Line of Business |
| LTC | Long Term Care insurance; typically helps pay for costs associated with long term care |
| LTS | Long Term Services; including but not limited to Life, Provident and Pension funds |
| Marketable Securities | Liquid financial assets that can be quickly converted into cash; most are trading assets |


| MF | Management Fees; wages charged by a financial manager |
|---|---|
| Moody's | A credit risk rating agency |
| MSCI | Morgan Stanley Capital International Emerging Markets Index; measures the performance in equity markets, specifically in global emerging markets |
| Mutual Fund | Open end, non-tradable basket of securities that tracks the performance of an undelaying index, sector, or security type |
| Net Inflows | The net amount of new cash, excluding the impact of investment market value; calculated by subtracting withdrawals from new deposits |
| NIS | New Israeli Shekel |
| Non-Marketable Securities | Asset group that is considered to be difficult to buy or sell due to the fact they are not traded on any major exchange; could include government issued debt securities, limited partnerships, real estate investments and more |
| Nostro | The account in which a financial institution manages its own funds |
| OPEX | Operational Expenses |
| P&C | Property and Casualty insurance |
| PH | Phoenix holdings |
| PHI | Permanent Health Insurance |
| PI | Phoenix insurance |
| PLI | Professional Liability insurance |
| Reinsurance | A balancing risk strategy; one or more insurers that share the liability |
| Revenue | All encompassing streams of income; including, but not limited to: premium, management fees, benefit contributions |
| RFR | Risk Free Rates |
| ROE | Return On Equity; calculated by dividing net income over total equity |
| SME60 | "The Rest Index"; tracks the performance of the 60 largest market value companies that are excluded from the Tel Aviv Stock Exchange |
| Special Items | Changes in profit or loss that are not part of the usual business of the Company, including changes in actuarial research, actuarial model changes, other structural changes and strategic acquisition costs in AM segment |
| Tel Bond 20 | Index that tracks the performance of the 20 largest Index Linked Corporate Bonds in terms of market value |
| Tel Bond 40 | Index that tracks the performance of the 40 largest Index Linked Corporate Bonds in terms of market value |
| Tel Bond 60 | Index that tracks the performance of the 60 largest Index linked Corporate Bonds in terms of market value |
| TLV 125 | An index that tracks the performance of the 125 largest market value companies in the Tel-Aviv Stock Exchange |
| TLV 35 | An index that tracks the performance of the 35 largest market value companies in the TLV Stock Exchange |
| TLV 90 | An index that tracks the performance of the 90 largest market value companies in the TLV stock Exchange |
| TMTP | Transitional Measures on Technical Provisions |
| Workers' Compensation Insurance | Insurance coverage for employees' injuries or sickness |
| Yield Curve | A line that plots interest rates of bonds with equal credit risk with different maturity dates in the future |


Please contact us at [email protected]
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.